201 related articles for article (PubMed ID: 38559466)
21. The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments.
Benbrahim O; Viallard JF; Choquet S; Royer B; Bauduer F; Decaux O; Crave JC; Fardini Y; Clerson P; Lévy V
Hematology; 2019 Dec; 24(1):173-182. PubMed ID: 30458690
[TBL] [Abstract][Full Text] [Related]
22. Clinical and laboratory characteristics of patients with symptomatic secondary immunodeficiency following the treatment of haematological malignancies.
Shields AM; Faustini SE; Young S; Terjesen S; McCarthy NI; Anderson RL; Drayson MT; Richter AG
EJHaem; 2023 May; 4(2):339-349. PubMed ID: 37206270
[TBL] [Abstract][Full Text] [Related]
23. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
24. Use of immunoglobulin replacement therapy in patients with secondary antibody deficiency in daily practice: a European expert Q&A-based review.
Cinetto F; Francisco IE; Fenchel K; Scarpa R; Montefusco V; Pluta A; Wolf HM
Expert Rev Hematol; 2023 Apr; 16(4):237-243. PubMed ID: 37009667
[TBL] [Abstract][Full Text] [Related]
25. IgG Testing, Immunoglobulin Replacement Therapy, and Infection Outcomes in Patients with CLL or NHL: Real-World Evidence.
Soumerai JD; Yousif Z; Gift T; Desai R; Huynh L; Ye M; Banatwala A; Clear L; Pinaire M; Belsky G; Hsieh YG; Herrick C; Darnell EP; Duh MS; Sanchirico M; Murphy SN
Blood Adv; 2024 Jun; ():. PubMed ID: 38904477
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment.
Wasserman RL
Allergy Asthma Proc; 2021 Nov; 42(6):489-494. PubMed ID: 34871156
[No Abstract] [Full Text] [Related]
27. Tracking health commodity inventory and notifying stock levels via mobile devices: a mixed methods systematic review.
Agarwal S; Glenton C; Henschke N; Tamrat T; Bergman H; Fønhus MS; Mehl GL; Lewin S
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012907. PubMed ID: 33539585
[TBL] [Abstract][Full Text] [Related]
28. Supportive care needs of women with gynaecological cancer: A systematic review and synthesis of qualitative studies.
Sun Y; Ma Y; Li Q; Ge J
J Adv Nurs; 2023 Aug; 79(8):2784-2801. PubMed ID: 36811244
[TBL] [Abstract][Full Text] [Related]
29. Understanding what affects psychological morbidity in informal carers when providing care at home for patients at the end of life: a systematic qualitative evidence synthesis.
Bayliss K; Shield T; Wearden A; Flynn J; Rowland C; Bee P; Farquhar M; Harris D; Hodkinson A; Panagioti M; Booth M; Cotterill D; Goodburn L; Knipe C; Grande G
Health Soc Care Deliv Res; 2023 Sep; ():1-53. PubMed ID: 37843444
[TBL] [Abstract][Full Text] [Related]
30. Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia.
Ohmoto A; Fuji S; Shultes KC; Savani BN; Einsele H
Bone Marrow Transplant; 2022 Jun; 57(6):874-880. PubMed ID: 35440805
[TBL] [Abstract][Full Text] [Related]
31. Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
Noto A; Cassin R; Mattiello V; Bortolotti M; Reda G; Barcellini W
Front Immunol; 2023; 14():1062376. PubMed ID: 37122737
[TBL] [Abstract][Full Text] [Related]
32. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
33. A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia.
Lachance S; Christofides AL; Lee JK; Sehn LH; Ritchie BC; Shustik C; Stewart DA; Toze CL; Haddad E; Vinh DC
Curr Oncol; 2016 Feb; 23(1):42-51. PubMed ID: 26966403
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic Antibiotics Versus Immunoglobulin Replacement in Specific Antibody Deficiency.
Joud Hajjar ; Nguyen AL; Constantine G; Kutac C; Syed MN; Orange JS; Sullivan KE
J Clin Immunol; 2020 Jan; 40(1):158-164. PubMed ID: 31758281
[TBL] [Abstract][Full Text] [Related]
35. Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland.
Edgar JDM; Richter AG; Huissoon AP; Kumararatne DS; Baxendale HE; Bethune CA; Garcez T; Misbah SA; Sorensen RU;
J Clin Immunol; 2018 Feb; 38(2):204-213. PubMed ID: 29423883
[TBL] [Abstract][Full Text] [Related]
36. Artificial intelligence technologies and compassion in healthcare: A systematic scoping review.
Morrow E; Zidaru T; Ross F; Mason C; Patel KD; Ream M; Stockley R
Front Psychol; 2022; 13():971044. PubMed ID: 36733854
[TBL] [Abstract][Full Text] [Related]
37. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin substitution in patients with secondary antibody deficiency in chronic lymphocytic leukemia and multiple myeloma: a representative analysis of guideline adherence and infections.
Link H; Kerkmann M; Holtmann L; ;
Support Care Cancer; 2022 Jun; 30(6):5187-5200. PubMed ID: 35257229
[TBL] [Abstract][Full Text] [Related]
39. Training Physicians to Provide High-Value, Cost-Conscious Care: A Systematic Review.
Stammen LA; Stalmeijer RE; Paternotte E; Oudkerk Pool A; Driessen EW; Scheele F; Stassen LP
JAMA; 2015 Dec; 314(22):2384-400. PubMed ID: 26647260
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
